General Information

Age Group

Adults

Status

Recruiting

Protocol Number

NCT06777368

Background Information

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo TAVR.

For more information, visit: https://clinicaltrials.gov/study/NCT06777368

Offered At

Inova Health Care Services                                                                   
3300 Gallows Road 
Falls Church, VA 22042

 
Principal Investigator

Matthew Sherwood, MD

Eligibility Information

  • BVF of a TAV (either Medtronic or Edwards) requiring redo TAVR

Ineligibility Information

  •        BVF due solely to paravalvular regurgitation
  •        Active endocarditis
  •        Untreated acute valve thrombosis
  •        Life-expectancy less than 1-year
  •        Subject is less than legal age of consent, legally incompetent, or otherwise vulnerable
  • Participating in another study that my influence the outcome of this study